Objective: To raise awareness on, and interest in, the role of the European Prevention Curriculum (EUPC) in advocating for the application of science-based strategies in policy- and decision-making at local level.
Jaringan Kebijakan Narkoba Eropa Tenggara dan Pusat Pemantauan Eropa untuk Narkoba dan Kecanduan Narkoba (EMCDDA) mengundang Anda untuk berpartisipasi dalam webinar yang akan memberikan informasi tentang strategi narkoba Uni Eropa yang...
Webinar ini merupakan bagian dari rangkaian webinar yang telah diselenggarakan EMCDDA selama setahun terakhir dengan tema COVID-19. Tujuan dari webinar ini adalah untuk membantu mereka yang bekerja di bidang narkoba memahami bagaimana...
This report presents new findings from the ESCAPE (European Syringe Collection and Analysis Project Enterprise) network, based on the chemical analysis of the contents of used syringes across sentinel sites in Europe.
Syringes were collected in 2018 and 2019 from the bins of street automatic injection-kit dispensers and at harm reduction services in eight European cities: Amsterdam, Budapest, Cologne, Helsinki, Lausanne, Oslo, Paris and Vilnius.
Laporan ini memberikan ringkasan singkat tentang beberapa tantangan, lama dan baru, yang dihadapi perempuan dan anak perempuan dalam konteks epidemi tembakau di Wilayah Eropa WHO, menguraikan sifat gender dari penggunaan dan paparan tembakau dan bagaimana industri tembakau terus menargetkan mereka melalui pesan gender. Ini juga memberikan rekomendasi untuk pendekatan dan intervensi kebijakan yang mengambil lensa gender untuk pengendalian tembakau.
Konvensi Kerangka Kerja WHO tentang Pengendalian Tembakau (WHO FCTC) sangat mendukung kesetaraan gender dan menyoroti pentingnya menangani risiko...
This report reviews how opioid substitution treatment (OST) is implemented in European countries and examines the public health consequences of the diversion and misuse of prescription OST medications.
It looks at how OST medications are diverted to the illicit market, the motivations behind diversion and misuse, and considers the measures to prevent diversion and how they must ensure that the treatment remains available and accessible for those who need it.
Objective: To explore innovative programmes providing solutions in the field of homelessness and drugs.
Background: The association between long-term homelessness, problem drug use and alcohol dependence are well documented. Evidence suggests that a relatively small, long-term and recurrently homeless population has a high prevalence of mental health problems and substance dependence. In the context of the current COVID-19 pandemic, there is much concern that the health and social wellbeing of members of this population will worsen. Addressing their diverse and complex needs is...
This strategy sets out an ambitious course of travel for the agency to 2025. It presents a vision to contribute to a healthier and more secure Europe, through better-informed drug policy and action.
Adopted unanimously by the agency’s key stakeholders in 2016, the strategy is the result of a year-long, in-depth analysis of the environment in which the EMCDDA operates.
This analysis focused, in particular, on customer needs and a critical review of our internal capacity to meet them.
Professionals, academics or experts from European Neighbourhood Policy (ENP) countries (1) will have an opportunity to participate in the European Drugs Winter and Summer Schools this year, thanks to 10 bursaries being offered through the EU4Monitoring Drugs (EU4MD) project.
The University Institute of Lisbon (ISCTE-IUL) and the EMCDDA are offering the two courses following the success of the European Drugs Summer School (EDSS) in 2020, taught remotely due to the COVID-19 pandemic.
The European Drugs Winter School (EDWS), taking place online from 1–12 March 2021, will focus on the theme of...
The first part of this report provides options for responses to counter the synthetic drug problem.
The second part presents a global thematic analysis of the key trends and emerging developments of the synthetic drugs market as well as the recent trends in the manufacture of synthetic drugs, including the effects of the COVID-19 pandemic.
The third part provides the key findings of the synthetic drug situation in the different regions of the world.
EUSPR are pleased to announce that the 12th EUSPR Conference and Members’ Meeting will take place online on 30th September – 1st October 2021, with workshops scheduled for the 29th September.
Konferensi Penelitian Internasional adalah organisasi federasi yang didedikasikan untuk menyatukan sejumlah besar acara ilmiah yang beragam untuk presentasi dalam program konferensi. Acara akan berjalan selama rentang waktu selama...
Dua minggu Summer School mempersiapkan para profesional dan siswa untuk memenuhi tantangan kebijakan kompleks yang dihadapi Eropa dan Dunia di bidang narkoba. Staf pengajar termasuk pakar ilmiah dari Pusat Pemantauan Eropa untuk Obat-obatan...
EMCDDA dan Institut Universitas Lisbon (ISCTE-IUL) menawarkan dua acara mendatang pada tahun 2021: Sekolah Musim Dingin Obat Eropa (EDWS) dan Sekolah Musim Panas Obat Eropa (EDSS).
EDWS akan berlangsung sebagai acara virtual dari 1–12...
The Pompidou Group calls for youth projects to submit applications for the 2021 edition of the European Drug Prevention Prize.
The Prevention Prize is awarded to highlight outstanding drug prevention projects that have proved successful in involving young people in their design, implementation and evaluation.
Up to three projects will be awarded a Prize. During the Award Ceremony, each will receive the Prize Trophy, the Prize Diploma and€5.000 to support implementation. Prize-winners tell us that winning the Prize has helped them gain greater recognition for their work.
The purpose of this technical report is to provide an analysis of the available information on methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (commonly known as 4F-MDMB-BICA), a synthetic receptor cannabinoid agonist that has recently emerged on the drug market in Europe, in order to support the risk assessment of the substance which has been requested by the European Commission.
Table of contents
Summary
Background
Chemical and physical properties, methods and the precursors used for manufacture or extraction
Reitox is the European information network on drugs and drug addiction created at the same time as the EMCDDA.
Members of the Reitox network are designated national institutions or agencies responsible for data collection and reporting on drugs and drug addiction. These institutions are called 'national focal points' or 'national drug observatories'.
This report highlights the responses taken by the EMCDDA's Reitox network of national focal points to the COVID-19 crisis and describes the challenges met by the organisations and the strategies produced to overcome these challenges.